Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

ING4 Inhibitors

ING4 inhibitors refer to a class of chemical compounds that target the inhibitor of growth 4 (ING4) protein, a member of the ING family of tumor suppressors. ING4, also known as inhibitor of growth 4, is a crucial modulator of various cellular processes, including chromatin remodeling, transcriptional regulation, and DNA repair. The ING family proteins are distinguished by their ability to interact with histone acetyltransferase and histone deacetylase complexes, contributing to the modulation of gene expression and epigenetic regulation. ING4 specifically acts as a bridge between chromatin and these enzyme complexes, exerting its functions through its conserved plant homeodomain (PHD) finger and nuclear localization signals. ING4 inhibitors are designed to interfere with the interactions between ING4 and its associated complexes, ultimately impacting its role in epigenetic regulation and gene expression modulation.

These inhibitors typically target the binding pocket of the PHD finger domain, disrupting its ability to interact with histones and other protein partners. By doing so, they can potentially alter the accessibility of DNA to transcriptional machinery, leading to downstream effects on cellular processes such as cell cycle progression, apoptosis, and DNA damage repair. Research into ING4 inhibitors is part of the broader effort to understand the intricate networks of epigenetic regulation and their influence on cellular behavior. These compounds serve as valuable tools in dissecting the functions of ING4 and its associated pathways, providing insights into potential mechanisms for controlling cellular processes through epigenetic modulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Tyrosine kinase inhibitor targeting BCR-ABL, c-KIT, and PDGFR. Blocks ATP binding, preventing phosphorylation cascade.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

EGFR tyrosine kinase inhibitor. Binds to ATP pocket, inhibiting receptor autophosphorylation and downstream signaling.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Multi-kinase inhibitor blocking RAF, VEGFR, PDGFR, and others. Disrupts tumor cell proliferation and angiogenesis.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dual BCR-ABL and SRC family kinase inhibitor. Binds to active conformation, inhibiting proliferation and survival.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor binding to FKBP12. Complex inhibits mTORC1, suppressing cell growth, proliferation, and autophagy.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

mTOR inhibitor similar to rapamycin. Slows cell cycle progression and angiogenesis by targeting mTORC1 complex.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Bruton's tyrosine kinase (BTK) inhibitor. Blocks B-cell receptor signaling, leading to apoptosis in B-cell malignancies.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

BCL-2 inhibitor disrupting mitochondrial apoptotic pathway. Induces apoptosis in B-cell lymphomas and leukemias.

CH5424802

1256580-46-7sc-364461
sc-364461A
5 mg
50 mg
$191.00
$902.00
(0)

ALK and RET kinase inhibitor. Blocks aberrant signaling in ALK-positive non-small cell lung cancer (NSCLC).